HCPCS Level IIdrugActive
J7311
Inj., retisert, 0.01 mg
BETOS: O1E
Effective: 2019-10-01
Referenced in 1 policies
Description
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Retisert
Manufacturer
Bausch & Lomb Americas Inc.
HCPCS Dosage
0.01 MG
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.